Prostaglandin E1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting

Journal of Clinical Anesthesia

Volumn 12, Issue 5, 2000, Pages 363-370

  Locker, Gottfried J ^a   Grimm, Michael ^a   Losert, Heidrun ^a   Stoiser, Brigitte ^a   Kofler, Julia ^a   Knapp, Sylvia ^a   Wilfing, Astrid ^a   Enoebl, Paul ^a   Kapiotis, Stylianos ^a   Czerny, Martin ^a   Muhm, Manfred ^a   Hiesmayr, Michael ^a   Frass, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blood loss, coagulation, complications; Prostaglandin E1

Indexed keywords

ACETYLSALICYLIC ACID; BIOCHEMICAL MARKER; DALTEPARIN; FIBRINOGEN; FRESH FROZEN PLASMA; PROSTAGLANDIN E1; THROMBOCYTE CONCENTRATE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; ERYTHROCYTE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LIVER; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOPLASTIN TIME;

EID: 0033812975     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(00)00170-7     Document Type: Article

References (27)

1. Dryden PJ, O'Connor JP, Jamieson WR, et al: Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth 1997;44:934-41.
2. Jamieson WR, Dryden PJ, O'Connor JP, Sadeghi H, Ansley DM, Merrick PM: Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Circulation 1997;96S:96-100.
3. Laupacis A, Fergusson D: Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1997; 85:1258-67.
4. el-Gatit A, al-Khaja N, Belboul A, Roberts D, William-Olsson G: Effects of alprostadil infusion during extracorporeal circulation on blood rheology and postoperative blood loss. Vasc Surg 1992;26:521-8.
5. Kozek-Langenecker SA, Wanzel O, Berger R, Kettner SC, Coraim F: Incrcased anticoagulation during cardiopulmonary bypass by prostaglandin E,. Anesth Analg 1998;87:985-8.
6. 1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1988;137:5-12.
7. 1 and survival in patients with the adult respiratory distress syndrome. A prospective trial. Ann Surg 1986;203:371-8.
8. 1 in adult respiratory distress syndrome. Surgery 1986;99:275-83.
9. 1 on non-pulmonary organ function during clinical acute respiratory failure. J Trauma 1992;32:480-8.
10. Freed MD, Heymann MA, Lewis AB, Roehl SL, Kensey RC: Prostaglandin El in infants with ductus arteriosus-dependent congenital heart disease. Circulation 1981;64:898-905.
11. 1 treatment of pulmonary hypertension. Am Rev Respir Dis 1987;136:773-6.
12. 1bridge to cardiac transplantation. Technique, dosage, results. Eur Heart J 1997;18:318-29.
13. Araki H, Lefer AM: Cytoprotective actions of prostacyclin during hypoxia in isolated perfused cat liver. Am J Physiol 1980;238:176-81.
14. 1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 1993;55:819-26.
15. 1. Transplantation 1989;48:447-53.
16. 1 for prevention and treatment of ARDS after surgery. In: Vincent JL (ed): Update in Intensive Care and Emergency Medicine. Berlin: Springer, 1989;80-5.
17. 1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade? J Trauma 1997;42: 525-31.
18. Brown RS, Thwaites BK, Mongan PD: Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Analg 1997;85:963-70.
19. Mongan PD, Brown RS, Thwaites BK: Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 1998;87:258-65.
20. 1 infusion on hemostasis in orthopic liver transplantation. Semin Thromb Hemost 1993;19: 273-8.
21. Born GV, Bergquist D, Arfors KE: Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes. Nature 1976;259:233-5.
22. Kloeze J: Influence of prostaglandins on platelet adhesiveness and platelet aggregation. In: Bergström S, Samuelsson B (eds): Proceedings of the Second Nobel Symposium. Stockholm: Almqvist and Wiksell, 1967;241-57.
23. 1,. J Pharmacol Exp Ther 1967;156:538-47.
24. 1, in man. J Clin Invest 1975;56:1404-10.
25. Heavey DJ, Barrow SE, Hickling NE, Ritter JM: Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985;318:186-8.
26. 2, glucagon and secretin on the hepatic arterial vascular bed of the dog. Br J Pharmacol 1976;57: 581-8.
27. Feely J, Wood AJ: Effect on apparent liver blood flow of histamine-receptor blockers and inhibition of prostaglandin synthesis Clin Pharmacol Ther 1983;33:91-4.